First Choice

• Octasa MR® (400mg e/c m/r tablets): approved as first choice 400mg e/c m/r preparation for all new patients. Patients receiving Asacol® and Mesren® should be switched to Octasa® when appropriate. 800mg & 1600mg e/c m/r tablets also approved for suitable patients - to reduce tablet burden.
• Asacol® (400mg e/c m/r tablets) - to be used for existing patients who are unable to change to Octasa MR®.
• Pentasa® (500mg & 1000mg m/r tablets).
• Mezavant® XL (1.2g e/c m/r tablets).
• Salofalk® (500mg, 1000mg, 1500mg & 3000mg m/r granules/sachet) - only to be used in patients with difficulty in swallowing.

Alternatives

• 500mg & 1g suppositories

• 1g in 100ml retention enema, 2g in 59ml enema

• 1g foam enema